/

Empresas

Tr

No verificado

Trogenix

Sobre qué escribimos

Anuncios brevesBiotecnologíaPublicidad/Marketing/Medios de comunicación/Comunicación

4 Comunicados de prensa

Ver todos los comunicados de prensa

05/10/2025

Biotecnología

Publicidad/Marketing/Medios de comunicación/Comunicación

Anuncios breves

Trogenix announces £70 million / $95 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers

Fuente

Editor

1.00

0

Press Release cover image

17/07/2025

Biotecnología

Publicidad/Marketing/Medios de comunicación/Comunicación

Anuncios breves

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development

Fuente

Editor

1.00

0

Press Release cover image

06/05/2025

Trogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher

Fuente

Editor

1.00

0

Press Release cover image

17/11/2024

Biotecnología

Publicidad/Marketing/Medios de comunicación/Comunicación

Anuncios breves

Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0